Related Experiment Video
Updated: Aug 10, 2026
08:17
Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy
Published on: June 7, 2015
Calculation of the 3-D dose distribution surrounding a 103Pd stent
L B McLemore1, J L Horton, J A Antolak
1Department of Radiation Physics, The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA.
Cardiovascular Radiation Medicine
|January 12, 2002
Summary
This study found that a 103Pd-implanted stent is suitable for intravascular brachytherapy. Dosimetry simulations confirm its potential for delivering precise radiation doses in blood vessels.
Area of Science:
- Medical Physics
- Radiotherapy
- Biomedical Engineering
Background:
- Intravascular brachytherapy is a treatment for restenosis.
- 103Pd is a radioisotope used in brachytherapy.
Purpose of the Study:
- To evaluate the suitability of a 103Pd-implanted stent for intravascular brachytherapy.
- To assess the dose distribution and requirements for this stent design.
Main Methods:
- A stent was modeled using Monte Carlo simulations (EGS4/DOSRZ).
- Dose calculations were performed for individual stent struts.
- Simulation parameters were validated against TG43 methods for a 103Pd seed.
Main Results:
- Dose profiles near the stent surface were heterogeneous, reflecting stent structure.
- Specific activity (2.68 x 10^7 Bq) was determined for a 2-mm stent to deliver 31.5 Gy.
- Monte Carlo simulations showed good agreement (within 7%) with TG43 calculations.
Conclusions:
- Dosimetric analysis supports the suitability of 103Pd-implanted stents for intravascular brachytherapy.
- The study provides essential data for the clinical application of these devices.
